Reply to Letter to the Editor: "Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease"

被引：0
|
作者：
Guzel, Tuncay [1 ]
Aktan, Adem [2 ]
Kilic, Raif [3 ]
Arslan, Bayram [4 ]
Demir, Muhammed [5 ]
Ozbek, Mehmet [5 ]
Ertas, Faruk [5 ]
机构：
[1] Univ Hlth Sci, Gazi Yasargil Training & Res Hosp, Dept Cardiol, Diyarbakir, Turkiye
[2] Mardin Training & Res Hosp, Dept Cardiol, Mardin, Turkiye
[3] Diyarlife Hosp, Dept Cardiol, Diyarbakir, Turkiye
[4] Ergani State Hosp, Dept Cardiol, Diyarbakir, Turkiye
[5] Dicle Univ, Dept Cardiol, Fac Med, Diyarbakir, Turkiye
来源：
ANATOLIAN JOURNAL OF CARDIOLOGY | 2023年 / 27卷 / 01期
关键词：
WARFARIN; MANAGEMENT;
D O I：
10.14744/AnatolJCardiol.2022.2335
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：56 / 58
页数：3
相关论文
共 50 条
  • [1] Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
    Undas, Anetta
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (01): : 54 - 55
  • [2] Real-life assessment of triple anticoagulation therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
    Bogacki, P.
    Kablak-Ziembicka, A.
    Bryniarski, K. L.
    Wrotniak, L.
    Ostrowska-Kaim, E.
    Zmudka, K.
    Przewlocki, T.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1163 - 1163
  • [3] Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation
    Baron-Esquivias, Gonzalo
    Fernandez-Aviles, Francisco
    Atienza, Felipe
    Pastor Pueyo, Pablo
    Toro, Rocio
    Sanmartin Fernandez, Marcelo
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (04) : 341 - 353
  • [4] Oral anticoagulation in patients undergoing elective cardioversion of atrial fibrillation. Real-life experience from Finland
    Itainen-Stromberg, S.
    Hekkala, A. -M.
    Aro, A.
    Vasankari, T.
    Airaksinen, J.
    Lehto, M.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1194 - 1194
  • [5] Renal Impairment in a "Real-Life" Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)
    Roldan, Vanessa
    Marin, Francisco
    Fernandez, Hermogenes
    Manzano-Fernandez, Sergio
    Gallego, Pilar
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (08): : 1159 - 1164
  • [6] Reply to Letter to the Editor: "The Role of Inflammation in Atrial Fibrillation"
    Omur, Sefa Erdi
    Zorlu, Cagri
    Yilmaz, Mustafa
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (12): : 738 - 738
  • [7] Bridging Anticoagulation in Patients with Atrial Fibrillation Reply
    Douketis, James D.
    Hasselblad, Vic
    Ortel, Thomas L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (01): : 93 - 94
  • [8] Real-Life Incident Atrial Fibrillation in Outpatients with Coronary Artery Disease
    Ninni, Sandro
    Lemesle, Gilles
    Meurice, Thibaud
    Tricot, Olivier
    Lamblin, Nicolas
    Bauters, Christophe
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 11
  • [9] Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Pokorney, Sean D.
    Black-Maier, Eric
    Piccini, Jonathan P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 351 - 352
  • [10] Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the 'Letter to the Editor' from Dr. Sorigue et al.
    Vedovati, Maria Cristina
    Giustozzi, Michela
    Agnelli, Giancarlo
    Becattini, Cecilia
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 280 : 97 - 97
12345